MedPath

Repetitive TMS and Occupational Therapy in Children and Young Adults With Chronic Hemiparesis

Not Applicable
Terminated
Conditions
Pediatric Stroke
Chronic Hemiparesis
Cerebral Palsy
Interventions
Device: Repetitive Transcranial Magnetic Stimulation
Device: Sham Repetitive Transcranial Magnetic Stimulation
Other: Occupational Therapy
Registration Number
NCT02057276
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Brief Summary

The purpose of this study is to determine whether Repetitive Transcranial Magnetic Stimulation (rTMS) can augment occupational therapy in improving motor function in children (10 years of age or older) and young adults (\< 21 years of age) with chronic hemiparesis from either stroke or cerebral palsy.

Detailed Description

RTMS is a noninvasive technology that can induce changes in brain function that may lead to functional improvement in people with hemiparesis. This is a randomized, double-blinded, sham-controlled rTMS study in conjunction with intensive daily occupational therapy (OT) for 2 weeks to improve motor function in hemiparetic patients. Participants will be followed for at least 12 weeks after rTMS to detect any clinical change. The sham group participants will be offered an open-label active rTMS treatment plus OT after the 12 week assessment.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Age ≥ 10 years; < 21 years
  • Hemiparesis
  • Manual Ability Classification System (MACS) level I through IV
  • Provision of written informed consent by the patient and/or guardian, including understanding that insurance may be billed for the occupational therapy
  • Written assent form signed by participants younger than 18 years of age
Exclusion Criteria
  • Underlying degenerative or metabolic disorder or supervening medical illness
  • Severe depression or other psychiatric disorder
  • Any participant who is pregnant
  • Any contraindication to TMS (i.e., intracranial metal implants, shunts, ports, pacemaker, baclofen pumps)
  • Any changes or addition of neuropsychiatric medications within 1 month of starting the study or during course of the study (if applicable)
  • Any botulinum toxin (Botox, Myobloc) or phenol injection within the last 3 months prior to the study or during the course of the study (if applicable)
  • Any upper extremity surgery within the last 6 months prior to the study or scheduled during the course of the study (if applicable)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active rTMSRepetitive Transcranial Magnetic StimulationParticipants will receive daily active rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays.
Active rTMSOccupational TherapyParticipants will receive daily active rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays.
Sham rTMSSham Repetitive Transcranial Magnetic StimulationParticipants will receive daily sham rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays.
Sham rTMSOccupational TherapyParticipants will receive daily sham rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays.
Primary Outcome Measures
NameTimeMethod
Change in the "Melbourne Assessment of Unilateral Upper Limb Function"Change in the "Melbourne Assessment of Unilateral Upper Limb Function" between baseline and 3 days after rTMS/OT
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath